Cargando…

Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion

IMPORTANCE: Clinical trial activity in Ukraine was seriously affected by the Russian invasion. However, data are lacking on how this conflict affects clinical trials. OBJECTIVE: To evaluate whether registered changes to trial information reflect war-related disturbances to trials in Ukraine. DESIGN,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gujinović, Diana, Viđak, Tomislav, Melnikova, Mariia, de Sousa, Nelson Joaquim Fortuna, Marušić, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293907/
https://www.ncbi.nlm.nih.gov/pubmed/37358852
http://dx.doi.org/10.1001/jamanetworkopen.2023.20202
_version_ 1785063085617184768
author Gujinović, Diana
Viđak, Tomislav
Melnikova, Mariia
de Sousa, Nelson Joaquim Fortuna
Marušić, Ana
author_facet Gujinović, Diana
Viđak, Tomislav
Melnikova, Mariia
de Sousa, Nelson Joaquim Fortuna
Marušić, Ana
author_sort Gujinović, Diana
collection PubMed
description IMPORTANCE: Clinical trial activity in Ukraine was seriously affected by the Russian invasion. However, data are lacking on how this conflict affects clinical trials. OBJECTIVE: To evaluate whether registered changes to trial information reflect war-related disturbances to trials in Ukraine. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included noncompleted trials conducted in Ukraine from February 24, 2022, to February 24, 2023. Trials conducted in Estonia and Slovakia were also analyzed for comparison. Study records within the ClinicalTrials.gov archive were accessed by using the change history feature in the tabular view for each record. EXPOSURE: Russian invasion of Ukraine. MAIN OUTCOMES AND MEASURES: The frequency of changes to the protocol and results registration parameters before and after the start of the war, February 24, 2022. RESULTS: A total of 888 ongoing trials conducted only in Ukraine (5.2%) or in multiple countries (94.8%), and enrolling a median of 348 participants were analyzed. Almost all sponsors for 775 industry-funded trials were non-Ukrainian (99.6%). On February 24, 2023, 267 trials (30.1%) were without any recorded update in the registry after the war. In 15 (1.7%) multisite trials, Ukraine was removed as a location country after mean (SD) of 9.4 (3.0) postwar months. The rates of changes in 20 parameters 1 year before and after the war started had a mean (SD) absolute difference of 3.0% (2.5%). Besides study status changes in each study record version, the contacts and locations field was the most frequently modified (56.1%), with a higher rate for multisite (58.2%) than in only Ukrainian (17.4%) trials. This finding was consistent for all analyzed registration parameters. In trials conducted solely in Ukraine, the median number of record versions was the year before (95% CI, 0-0) and after February 2022 (95% CI, 0-1), similar to registered trials from Estonia and Slovakia. CONCLUSIONS AND RELEVANCE: Results of this study suggest that war-related changes in trial conduct in Ukraine may not be completely visible in the largest public trial registry, which is expected to present accurate and timely information on clinical trials. These findings raise questions regarding the updating practices for registration information, which should be mandatory, especially in times of crises, to ensure the safety and the rights of trial participants in a war zone.
format Online
Article
Text
id pubmed-10293907
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-102939072023-06-28 Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion Gujinović, Diana Viđak, Tomislav Melnikova, Mariia de Sousa, Nelson Joaquim Fortuna Marušić, Ana JAMA Netw Open Original Investigation IMPORTANCE: Clinical trial activity in Ukraine was seriously affected by the Russian invasion. However, data are lacking on how this conflict affects clinical trials. OBJECTIVE: To evaluate whether registered changes to trial information reflect war-related disturbances to trials in Ukraine. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included noncompleted trials conducted in Ukraine from February 24, 2022, to February 24, 2023. Trials conducted in Estonia and Slovakia were also analyzed for comparison. Study records within the ClinicalTrials.gov archive were accessed by using the change history feature in the tabular view for each record. EXPOSURE: Russian invasion of Ukraine. MAIN OUTCOMES AND MEASURES: The frequency of changes to the protocol and results registration parameters before and after the start of the war, February 24, 2022. RESULTS: A total of 888 ongoing trials conducted only in Ukraine (5.2%) or in multiple countries (94.8%), and enrolling a median of 348 participants were analyzed. Almost all sponsors for 775 industry-funded trials were non-Ukrainian (99.6%). On February 24, 2023, 267 trials (30.1%) were without any recorded update in the registry after the war. In 15 (1.7%) multisite trials, Ukraine was removed as a location country after mean (SD) of 9.4 (3.0) postwar months. The rates of changes in 20 parameters 1 year before and after the war started had a mean (SD) absolute difference of 3.0% (2.5%). Besides study status changes in each study record version, the contacts and locations field was the most frequently modified (56.1%), with a higher rate for multisite (58.2%) than in only Ukrainian (17.4%) trials. This finding was consistent for all analyzed registration parameters. In trials conducted solely in Ukraine, the median number of record versions was the year before (95% CI, 0-0) and after February 2022 (95% CI, 0-1), similar to registered trials from Estonia and Slovakia. CONCLUSIONS AND RELEVANCE: Results of this study suggest that war-related changes in trial conduct in Ukraine may not be completely visible in the largest public trial registry, which is expected to present accurate and timely information on clinical trials. These findings raise questions regarding the updating practices for registration information, which should be mandatory, especially in times of crises, to ensure the safety and the rights of trial participants in a war zone. American Medical Association 2023-06-26 /pmc/articles/PMC10293907/ /pubmed/37358852 http://dx.doi.org/10.1001/jamanetworkopen.2023.20202 Text en Copyright 2023 Gujinović D et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Gujinović, Diana
Viđak, Tomislav
Melnikova, Mariia
de Sousa, Nelson Joaquim Fortuna
Marušić, Ana
Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title_full Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title_fullStr Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title_full_unstemmed Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title_short Changes in Registration Parameters for Ongoing Clinical Trials in Ukraine After 2022 Russian Invasion
title_sort changes in registration parameters for ongoing clinical trials in ukraine after 2022 russian invasion
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293907/
https://www.ncbi.nlm.nih.gov/pubmed/37358852
http://dx.doi.org/10.1001/jamanetworkopen.2023.20202
work_keys_str_mv AT gujinovicdiana changesinregistrationparametersforongoingclinicaltrialsinukraineafter2022russianinvasion
AT viđaktomislav changesinregistrationparametersforongoingclinicaltrialsinukraineafter2022russianinvasion
AT melnikovamariia changesinregistrationparametersforongoingclinicaltrialsinukraineafter2022russianinvasion
AT desousanelsonjoaquimfortuna changesinregistrationparametersforongoingclinicaltrialsinukraineafter2022russianinvasion
AT marusicana changesinregistrationparametersforongoingclinicaltrialsinukraineafter2022russianinvasion